ABBOTT LABORATORIES — Director's Dealing 2016

Feb 23, 2016

SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION

OMB APPROVAL

Washington, D.C. 20549

Check this box if no longer subjectto Section 16. Form 4 or Form 5 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP obligations may continue. See Instruction 1(b).

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB Number: 3235-0287 Estimated average burden hours per response: 0.5

1. Name and Address of Reporting Person[*] 2. Issuer Name and Ticker or Trading Symbol 5. Relationship of Reporting Person(s) to Issuer Pavee Jean-Yves ABBOTT LABORATORIES [ ABT ] (Check all applicable) Director 10% Owner 3. Date of Earliest Transaction (Month/Day/Year) Officer (give title Other (specify (Last) (First) (Middle) 02/19/2016 X below) below) 100 ABBOTT PARK ROAD Senior Vice President 4. If Amendment, Date of Original Filed (Month/Day/Year) 6. Individual or Joint/Group Filing (Check Applicable (Street) Line) ABBOTT PARK IL 60064 X Form filed by One Reporting Person Form filed by More than One Reporting Person (City) (State) (Zip)

==> picture [540 x 247] intentionally omitted <==

----- Start of picture text ----- Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned1. Title of Security (Instr. 3) 2. Transaction 2A. Deemed 3. 4. Securities Acquired (A) or 5. Amount of 6. Ownership 7. NatureDate Execution Date, Transaction Disposed Of (D) (Instr. 3, 4 Securities Form: Direct of Indirect(Month/Day/Year) if any Code (Instr. and 5) Beneficially (D) or Beneficial(Month/Day/Year) 8) Owned Indirect (I) OwnershipFollowing (Instr. 4) (Instr. 4)ReportedCode V Amount (A) or Price Transaction(s)(D)(Instr. 3 and 4)Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned(e.g., puts, calls, warrants, options, convertible securities)1. Title of 2. 3. Transaction 3A. Deemed 4. 5. Number 6. Date Exercisable and 7. Title and 8. Price 9. Number of 10. 11. NatureDerivative Conversion Date Execution Date, Transaction of Expiration Date Amount of of derivative Ownership of IndirectSecurity or Exercise (Month/Day/Year) if any Code (Instr. Derivative (Month/Day/Year) Securities Derivative Securities Form: Beneficial(Instr. 3) Price of (Month/Day/Year) 8) Securities Underlying Security Beneficially Direct (D) OwnershipDerivative Acquired Derivative Security (Instr. 5) Owned or Indirect (Instr. 4)Security (A) or (Instr. 3 and 4) Following (I) (Instr.Disposed Reported 4)of (D) Transaction(s)(Instr. 3, 4 (Instr. 4)and 5)AmountorNumberDate Expiration ofCode V (A) (D) Exercisable Date Title SharesOptionCommon(right to $ 38.4 02/19/2016 A 194,063 02/19/2017 02/18/2026 shares 194,063 $ 0 194,063 Dbuy)(1)----- End of picture text -----

Explanation of Responses:

1. Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 64,688 on 02/19/2017, 64,687 on 02/19/2018, and 64,688 on 02/19/2019.

John A. Berry, by power ofattorney for Jean-Yves Pavee** Signature of Reporting Person	02/23/2016Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

• If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

• ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.